Advanced in Prostate Cancer

Axel Hegele

Marburg An Der Lahn, HE, DE 
Advanced in Prostate Cancer
Marburg An Der Lahn, HE, DE 
OverviewLocationsClinical Research

Overview

Axel Hegele practices in Marburg An Der Lahn, Germany. Mr. Hegele is rated as an Advanced expert by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Lithotripsy, and Cystectomy.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 21 articles in the study of Prostate Cancer.

Gender
Male

Locations

Marburg An Der Lahn, HE, Germany
Other Locations
Biedenkopf, HE, Germany
Hessen, ST, Germany
Munich, BY, Germany
Giessen, HE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2025
Intervention Type: Drug
Study Drugs: abnobaVISCUM 900, Mitomycin C
Study Phase: Phase 3
Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)
Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO)
Enrollment Status: Withdrawn
Publish Date: February 13, 2018
Intervention Type: Drug, Procedure
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

71 Total Publications

Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer.
Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer.
Journal: BMC cancer
Published: December 19, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hegele's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile